Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: Results from the initial phase of a cluster randomized controlled trial in southern China

American Journal of Epidemiology

Volumn 177, Issue 3, 2013, Pages 242-250

  Liu, Zhiwei ^a   Ji, Ming Fang ^b   Huang, Qi Hong ^c   Fang, Fang ^d   Liu, Qing ^a   Jia, Wei Hua ^e   Guo, Xiang ^e   Xie, Shang Hang ^a   Chen, Feng ^a   Liu, Yue ^a   Mo, Hao Yuan ^e   Liu, Wan Li ^e   Yu, Yuan Long ^b   Cheng, Wei Min ^b   Yang, You Ye ^b   Wu, Biao Hua ^b   Wei, Kuang Rong ^b   Ling, Wei ^c   Lin, Xiao ^c   Lin, Er Hong ^c   Ye, Weimin ^d   Hong, Ming Huang ^a   Zeng, Yi Xin ^e   Cao, Su Mei ^a   more..

^a SUN YAT SEN UNIVERSITY   (China)

^b Cancer Research Institute of Zhongshan   (China)

^c Sihui Cancer Institute   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

biomarker; early detection; Epstein Barr virus; mass screening; nasopharyngeal carcinoma

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; VIRUS ANTIBODY;

ANTIBODY; ANTIGEN; BIOMARKER; CANCER; HEALTH RISK; MORTALITY; VIRUS;

ADULT; ARTICLE; CANCER SCREENING; CHINA; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; FIBERSCOPE ENDOSCOPY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NASOPHARYNX CARCINOMA; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; TUMOR BIOPSY;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CHINA; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS;

CHINA; GUANGDONG; SIHUI; ZHONGSHAN;

HUMAN HERPESVIRUS 4; MIRIDAE;

EID: 84874482029     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws404     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178. (doi:10.1186/1471- 2407-6-178). (Pubitemid 44308903)
3. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30(2):114-119.
4. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5(5):423-428. (Pubitemid 38612865)
5. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12(6):431-441. (Pubitemid 35370756)
6. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-768. (Pubitemid 39331148)
7. Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 1997;3(4):355-361.
8. Mao YP, Li WF, Chen L, et al. A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma. (In Chinese). Ai Zheng. 2009;28(10):1022-1028.
9. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer. 1982;29(2):139-141. (Pubitemid 12166994)
10. Zeng Y, Zhong JM, Li LY, et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology. 1983;20(4):190-194. (Pubitemid 14237237)
11. Zeng Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res. 1985;44:121-138.
12. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer. 1985;36(5):545-547. (Pubitemid 16233512)
13. Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992; 69(1):3-7.
14. Karray H, Ayadi W, Fki L, et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol. 2005;75(4):593-602. (Pubitemid 40293528)
15. Chan KH, Gu YL, Ng F, et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003;105(5): 706-709. (Pubitemid 36687741)
16. Tang JW, Rohwader E, Chu IM, et al. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma. J Clin Virol. 2007; 40(4):284-288. (Pubitemid 350152005)
17. Liu Y, Huang Q, Liu W, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer. 2012;131(2):406-416.
18. Wei K, Xu Y, Liu J, et al. No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007. Asian Pac J Cancer Prev. 2010; 11(6):1595-1599.
19. Wei KR, Yu YL, Yang YY, et al. Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev. 2010;11(1):29-32.
20. Gan YY, Fones-Tan A, Chan SH, et al. Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma. J Biomed Sci. 1996;3(3):159-169. (Pubitemid 26290746)
21. Chen MR, Liu MY, Hsu SM, et al. Use of bacterially expressed EBNA-1 protein cloned from a nasopharyngeal carcinoma (NPC) biopsy as a screening test for NPC patients. J Med Virol. 2001;64(1):51-57.
22. Cao SM, Liu Z, Jia WH, et al. Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One. 2011;6(4):e19100. (doi:10.1371/journal.pone.00191).
23. Pepe MS, Feng Z, Janes H, et al. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst. 2008; 100(20):1432-1438.
24. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer. 1993;71(8):2689-2697. (Pubitemid 23100513)
25. Lin ZX, Yang ZN, Zhan YZ, et al. Application study of the 2008 staging system of nasopharyngeal carcinoma. (In Chinese). Ai Zheng. 2009;28(10):1029- 1032.
26. Ji MF, Wang DK, Yu YL, et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer. 2007;96(4): 623-630.
27. Hsu WL, Chen JY, Chien YC, et al. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9, 622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1218-1226.
28. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041- 2054. (Pubitemid 40812341)
29. Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054-1061. (Pubitemid 32717537)